CHST14 and Dravet syndrome: We developed CRISPR/Cas9-genome engineered Chst14 mutant (Chst14–/–) mice, which showed a pathological phenotype and shared the typical mcEDS phenotype features, including loss of DS, growth delay, skin fragility, myopathy, reduced muscle function, and thoracic kyphosis.